enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pfizer reports patient death in Duchenne gene therapy study - AOL

    www.aol.com/news/pfizer-reports-patient-death...

    (Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular ...

  3. Physical therapy for Duchenne muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Physical_therapy_for...

    Devices to help a person with duchenne muscular dystrophy stand are a common treatment approach. [3] Orthotic devices are used (as discussed above) and also specific standing devices such as standing frames, standing wheelchairs, and tables that have a tilt function.

  4. Duchenne muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Duchenne_muscular_dystrophy

    Duchenne muscular dystrophy is a rare progressive disease that eventually affects all voluntary muscles and involves the heart and breathing muscles in later stages. Life expectancy is estimated to be around 25–26, [18] [59] but this varies. People born with Duchenne muscular dystrophy after 1990 have a median life expectancy of approximately ...

  5. Muscular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Muscular_Dystrophy

    The cardiac problems that occur with Emery–Dreifuss muscular dystrophy (EDMD) and myotonic muscular dystrophy may require a pacemaker. [29] The myotonia (delayed relaxation of a muscle after a strong contraction) occurring in myotonic muscular dystrophy may be treated with medications such as quinine.

  6. List of neuromuscular disorders - Wikipedia

    en.wikipedia.org/wiki/List_of_neuromuscular...

    Distal muscular dystrophy, also called distal myopathy, is essentially any muscle disease that preferentially affects the hands and/or feet, a much less common pattern than proximal muscle weakness. Late adult-onset type 1

  7. Deflazacort - Wikipedia

    en.wikipedia.org/wiki/Deflazacort

    The U.S. Food and Drug Administration approved deflazacort to treat people age five years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system. [5]

  8. Progressive muscular atrophy - Wikipedia

    en.wikipedia.org/wiki/Progressive_muscular_atrophy

    Progressive muscular atrophy (PMA), also called Duchenne–Aran disease and Duchenne–Aran muscular atrophy, is a disorder characterised by the degeneration of lower motor neurons, resulting in generalised, progressive loss of muscle function.

  9. A fatal disease is spreading among US deer, but there ... - AOL

    www.aol.com/news/2017-11-23-a-fatal-disease-is...

    An untreatable deer ailment similar to mad cow disease is spreading across America, impacting counties in Michigan and Montana. A fatal disease is spreading among US deer, but there may be a new ...